Alex J. Thompson

Alex J. Thompson

Auto-generated profile, based on publicly available information

Alex J. Thompson

Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2013 in Langmuir
Verified
Journal Article
Closed access
KNKatawut Namdee
Katawut Namdee
ATAlex J. Thompson
Alex J. Thompson
PCPhapanin Charoenphol
Phapanin Charoenphol
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

1 July 2013 in Biomaterials
Verified
Journal Article
Closed access
ATAlex J. Thompson
Alex J. Thompson
EMEric M. Mastria
Eric M. Mastria
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

26 January 2015 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
MFMargaret B. Fish
Margaret B. Fish
ATAlex J. Thompson
Alex J. Thompson
CFCatherine A Fromen
Catherine A Fromen
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

1 November 2014 in Atherosclerosis
Verified
Journal Article
Closed access
KNKatawut Namdee
Katawut Namdee
ATAlex J. Thompson
Alex J. Thompson
AGAlexander Golinski
Alexander Golinski
SMSupriya Mocherla
Supriya Mocherla
DBDiane Bouis
Diane Bouis
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

1 March 2017 in Biomicrofluidics
Verified
Journal Article
Closed access
ATA. J. Thompson
A. J. Thompson
LML. H. Marks
L. H. Marks
MGM. J. Goudie
M. J. Goudie
ARAlvaro Rojas-Peña
Alvaro Rojas-Peña
HHH. Handa
H. Handa
JPJoseph Potkay
Joseph Potkay
Artificial lungs have been used in the clinic for multiple decades to supplement patient pulmonary function. Recently, small-scale microfluidic artificial lungs (μAL) have been demonstrated with large surface area to blood volume ratios, biomimetic blood flow paths, and pressure drops compatible with pumpless operation. Initial small-scale microfluidic devices with blood flow rates in the μl/min to ml/min range have exhibited excellent gas transfer efficiencies; however, current manufacturing techniques may not be suitable for scaling up to human applications. Here, we present a new manufacturing technology for a microfluidic artificial lung in which the structure is assembled via a continuous “rolling” and bonding procedure from a single, patterned layer of polydimethyl siloxane (PDMS). This method is demonstrated in a small-scale four-layer device, but is expected to easily scale to larger area devices. The presented devices have a biomimetic branching blood flow network, 10 μm tall artificial capillaries, and a 66 μm thick gas transfer membrane. Gas transfer efficiency in blood was evaluated over a range of blood flow rates (0.1–1.25 ml/min) for two different sweep gases (pure O2, atmospheric air). The achieved gas transfer data closely follow predicted theoretical values for oxygenation and CO2 removal, while pressure drop is marginally higher than predicted. This work is the first step in developing a scalable method for creating large area microfluidic artificial lungs. Although designed for microfluidic artificial lungs, the presented technique is expected to result in the first manufacturing method capable of simply and easily creating large area microfluidic devices from PDMS.

22 August 2018 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
ATAlex J. Thompson
Alex J. Thompson
LMLindsay Juhee Ma
Lindsay Juhee Ma
TPThomas J. Plegue
Thomas J. Plegue
JPJoseph Potkay
Joseph Potkay
Objective: Microfluidic artificial lungs (μALs) are being researched for future clinical use due to the potential for increased gas exchange efficiency, small blood contacting surface area, small priming volume, and biomimetic blood flow paths. However, a current roadblock to clinical use is the need to stack hundreds to thousands of these small-scale μALs in parallel to reach clinically relevant blood flows. The need for so many layers not only increases the complexity and projected cost to manufacture a μAL, but also could result in devices which are cumbersome, and, therefore, not suitable for portable artificial lung systems. Methods: Here, we describe the design analysis and optimization of a single-layer μAL that simultaneously calculates rated blood flow, blood contacting surface area, blood volume, pressure drop, and shear stress as a function of blood channel height using previously developed closed-form mathematical equations. A μAL designed using this procedure is then implemented and tested. Results: The resulting device exhibits a rated flow of 17 mL/min and reduces the number of layers required for clinically relevant μAL devices by a factor of up to 32X compared to previous work. Conclusion: This procedure could significantly reduce manufacturing complexity as well as eliminate a barrier to the clinical application of these promising devices. Significance: The described method results in the highest rated flow for any single-layer μAL to date.